Alani; Laman
Patent Applications and Registrations
Patent applications and USPTO patent grants for Alani; Laman.The latest application filed is for "extended local release of antibodies".
Company Profile
1.30.31
- Alani; Laman - Menlo Park CA
- Alani; Laman - Fort Worth TX
- Alani; Laman - Forth Worth TX
- Alani; Laman - Hillsborough CA
- Alani; Laman - Foster City CA
- Alani; Laman - Lansdale PA US
- Alani; Laman - Morris Plains NJ
- Alani, Laman - Ann Arbor MI
Patent Activity
| Patent | Date |
|---|---|
| Extended local release of anti-CSFR1 antibodies Grant 11,427,641 - Alani , et al. August 30, 2 | 2022-08-30 |
| High concentration formulations of anti-CSF1 and anti-CSF1R antibodies Grant 11,419,822 - Alani , et al. August 23, 2 | 2022-08-23 |
| Extended Local Release Of Antibodies App 20220204632 - Alani; Laman ; et al. | 2022-06-30 |
| High Concentration Formulations Of Anti-csf1 And Anti-csf1r Antibodies App 20220183979 - Alani; Laman ; et al. | 2022-06-16 |
| Stable Protein Solution Formulation Containing High Concentration Of An Anti-vegf Antibody App 20200270336 - Zhang; Huixiang ; et al. | 2020-08-27 |
| Stable protein solution formulation containing high concentration of an anti-VEGF antibody Grant 10,689,438 - Zhang , et al. | 2020-06-23 |
| Controlled release formulations of levodopa and uses thereof Grant 9,901,640 - Hsu , et al. February 27, 2 | 2018-02-27 |
| Controlled Release Formulations Of Levodopa And Uses Thereof App 20170100480 - Hsu; Ann ; et al. | 2017-04-13 |
| High Concentration Olopatadine Ophthalmic Composition App 20170071895 - Gamache; Daniel A. ; et al. | 2017-03-16 |
| High concentration olopatadine ophthalmic composition Grant 9,533,053 - Gamache , et al. January 3, 2 | 2017-01-03 |
| Controlled release formulations of levodopa and uses thereof Grant 9,533,046 - Hsu , et al. January 3, 2 | 2017-01-03 |
| Finafloxacin suspension compositions Grant 9,504,691 - Boudreaux , et al. November 29, 2 | 2016-11-29 |
| Stable Protein Solution Formulation Containing High Concentration Of An Anti-vegf Antibody App 20160340420 - Zhang; Huixiang ; et al. | 2016-11-24 |
| Finafloxacin Suspension Compositions App 20160279137 - Boudreaux; Brent G. ; et al. | 2016-09-29 |
| Controlled Release Formulations Of Levodopa And Uses Thereof App 20160089438 - Hsu; Ann ; et al. | 2016-03-31 |
| Flavoring systems for pharmaceutical compositions and methods of making such compositions Grant 8,895,051 - Alani , et al. November 25, 2 | 2014-11-25 |
| High Concentration Olopatadine Ophthalmic Composition App 20140296328 - Gamache; Daniel A. ; et al. | 2014-10-02 |
| High concentration olopatadine ophthalmic composition Grant 8,791,154 - Gamache , et al. July 29, 2 | 2014-07-29 |
| Solid Pharmaceutical Dosage Form App 20140179721 - Rosenberg; Joerg ; et al. | 2014-06-26 |
| Finafloxacin Suspension Compositions App 20140162990 - Boudreaux; Brent G. ; et al. | 2014-06-12 |
| Solid pharmaceutical dosage form Grant 8,691,878 - Rosenberg , et al. April 8, 2 | 2014-04-08 |
| Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions App 20130252985 - Alani; Laman ; et al. | 2013-09-26 |
| Flavoring systems for pharmaceutical compositions and methods of making such compositions Grant 8,501,219 - Alani , et al. August 6, 2 | 2013-08-06 |
| Controlled release formulations of levodopa and uses thereof Grant 8,454,998 - Hsu , et al. June 4, 2 | 2013-06-04 |
| Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin Grant 8,414,921 - Kamali , et al. April 9, 2 | 2013-04-09 |
| Solid Pharmaceutical Dosage Form App 20130072508 - Rosenberg; Joerg ; et al. | 2013-03-21 |
| Solid pharmaceutical dosage form Grant 8,399,015 - Rosenberg , et al. March 19, 2 | 2013-03-19 |
| Controlled release formulations of levodopa and uses thereof Grant 8,377,474 - Hsu , et al. February 19, 2 | 2013-02-19 |
| Solid Pharmaceutical Dosage Formulation App 20130004578 - Rosenberg; Jorg ; et al. | 2013-01-03 |
| Solid pharmaceutical dosage form Grant 8,333,990 - Rosenberg , et al. December 18, 2 | 2012-12-18 |
| High Concentration Olopatadine Ophthalmic Composition App 20120295967 - Gamache; Daniel A. ; et al. | 2012-11-22 |
| Solid pharmaceutical dosage form Grant 8,309,613 - Rosenberg , et al. November 13, 2 | 2012-11-13 |
| Solid pharmaceutical dosage form Grant 8,268,349 - Rosenberg , et al. September 18, 2 | 2012-09-18 |
| Controlled Release Formulations Of Levodopa And Uses Thereof App 20120177731 - Hsu; Ann ; et al. | 2012-07-12 |
| Solid pharmaceutical dosage form Grant 8,025,899 - Berndl , et al. September 27, 2 | 2011-09-27 |
| Pharmaceutical formulations Grant 7,981,911 - Alani , et al. July 19, 2 | 2011-07-19 |
| Pharmaceutical Compositions Of Atorvastatin App 20110165239 - Alani; Laman ; et al. | 2011-07-07 |
| Solid Pharmaceutical Dosage Form App 20110015216 - Berndl; Gunther ; et al. | 2011-01-20 |
| Controlled Release Formulations Of Levodopa And Uses Thereof App 20100298268 - Hsu; Ann ; et al. | 2010-11-25 |
| Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions App 20100280055 - Alani; Laman ; et al. | 2010-11-04 |
| Taste-Masked Tablets and Granules App 20090136570 - Rege; Bhagwant ; et al. | 2009-05-28 |
| Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors With Metformin App 20090105265 - Kamali; Ashkan ; et al. | 2009-04-23 |
| Pharmaceutical Formulations App 20090053305 - Alani; Laman ; et al. | 2009-02-26 |
| Pharmaceutical formulations Grant 7,432,294 - Alani , et al. October 7, 2 | 2008-10-07 |
| Solid Pharmaceutical Dosage Formulations App 20080181948 - Berndl; Gunther ; et al. | 2008-07-31 |
| Pharmaceutical formulations App 20070032436 - Alani; Laman ; et al. | 2007-02-08 |
| Pharmaceutical formulations App 20070032435 - Alani; Laman ; et al. | 2007-02-08 |
| Pharmaceutical formulations Grant 7,141,593 - Alani , et al. November 28, 2 | 2006-11-28 |
| Flavoring systems for pharmaceutical compositions and methods of making such compositions App 20050191324 - Alani, Laman ; et al. | 2005-09-01 |
| Flavoring systems for pharmaceutical compositions and methods of making such compositions Grant 6,911,214 - Alani , et al. June 28, 2 | 2005-06-28 |
| Pharmaceutical compositions of amlodipine and atorvastatin App 20050107446 - Alani, Laman ; et al. | 2005-05-19 |
| Solid pharmaceutical dosage form App 20050048112 - Breitenbach, Jorg ; et al. | 2005-03-03 |
| Pharmaceutical compositions of amlodipine and atorvastatin App 20030114497 - Alani, Laman ; et al. | 2003-06-19 |
| Flavoring systems for pharmaceutical compositions and methods of making such compositions App 20020090445 - Alani, Laman ; et al. | 2002-07-11 |
| Retroviral protease inhibiting compounds Grant 6,284,767 - Sham , et al. September 4, 2 | 2001-09-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 